CLR Medical
Private Company
Funding information not available
Overview
CLR Medical is a private medical device company focused on solving the clinical problem of retained hemothorax through its innovative irrigation system. Its core technology platform consists of two complementary, patented devices: the CLR Irrigator, an ergonomic suction/irrigation tool for one-handed lavage, and the CLR Port, an access port that allows for repeated sterile irrigation without breaking the closed drainage circuit. The company is commercial-stage, targeting adoption in hospital trauma and thoracic surgery settings to improve patient outcomes and reduce healthcare costs associated with complications from retained blood. Leadership is led by an engineer-founder with a focus on customer-driven design.
Technology Platform
A proprietary, integrated system for closed thoracic irrigation consisting of the CLR Irrigator (a one-handed suction/irrigation device) and the CLR Port (an in-line access port for sterile, repeated lavage without breaking the drainage circuit).
Opportunities
Risk Factors
Competitive Landscape
Competes against makeshift irrigation setups using syringes and stopcocks, which are the current standard but are cumbersome and break the sterile circuit. Also faces indirect competition from alternative treatments for retained hemothorax like intrapleural fibrinolytic therapy (e.g., tPA) and VATS. No direct, branded competitor offering a dedicated integrated irrigation system was identified.